Arlinton Capital Partners’ portfolio company Riverpoint Medical (Riverpoint), a Portland, Oregon-based developer, designer, and manufacturer of medical devices focused on advanced surgical fibre implants and related technologies, has appointed Doug J King as Chief Executive Officer.
King most recently served as President of Medtronic’s Spinal business, leading the multi-billion dollar division within Medtronic’s Restorative Therapies Group. With more than 30 years of medical device industry expertise, King brings a wealth of experience and insight into the fast growing markets that Riverpoint serves.
“The Riverpoint team has built an outstanding business focused on developing and manufacturing polymer-based, advanced medical device products in the rapidly expanding sports medicine, animal health and regenerative end markets. I am excited by the opportunity to partner with Riverpoint and Arlington Capital Partners to accelerate the Company’s growth and build on the strong momentum the team has cultivated since founding the business,” says King.
Pat Ferguson, who has served as CEO since Riverpoint’s founding will remain highly involved with Riverpoint’s customer driven focus, and continue as a member of the Board of Directors.
“I am proud to have founded and helped grow Riverpoint into the Company it has become today,”says Ferguson. “This could not have been done without a lot of hard work and determination from all of the founders and team members. The Riverpoint and Arlington partnership will continue to focus its efforts on high quality, innovative, and advanced technologies that help improve the quality of life.”
Matt Altman, a Managing Partner at Arlington Capital Partners, says: “Doug is a leading executive in the medical device world and we are thrilled to have him join Riverpoint. We look forward to working with him to accelerate Riverpoint’s growth as we enter new markets and expand our existing offerings.”